Natural killer cells in graftversus-host disease and graft-versus-leukemia - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 350

[77] Lo Monaco E, Tremante E, Cerboni C, Melucci E, Sibilio L, Zingoni A, et al. Human
leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.
Neoplasia 2011;13(9):822-30.
[78] Foley B, De Santis D, Lathbury L, Christiansen F, Witt C. KIR2DS1-mediated activation
overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int Immunol
2008;20(4):555-63.
[79] Cooley S, Trachtenberg E, Bergemann TL, Saeteurn K, Klein J, Le CT, et al. Donors with
group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic
cell transplantation for acute myelogenous leukemia. Blood 2009;113(3):726-32.
[80] Nguyen S, Dhedin N, Vernant JP, Kuentz M, Al Jijakli A, Rouas-Freiss N, et al. NK-cell
reconstitution after haploidentical hematopoietic stem-cell transplantations: im-
maturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood
2005;105(10):4135-42.
[81] Vago L, Forno B, Sormani MP, Crocchiolo R, Zino E, Di Terlizzi S, et al. Temporal, quan-
titative, and functional characteristics of single-KIR-positive alloreactive natural killer
cell recovery account for impaired graft-versus-leukemia activity after haploidentical
hematopoietic stem cell transplantation. Blood 2008;112(8):3488-99.
[82] Cooley S, McCullar V, Wangen R, Bergemann TL, Spellman S, Weisdorf DJ, et al. KIR re-
constitution is altered by T cells in the graft and correlates with clinical outcomes after
unrelated donor transplantation. Blood 2005;106(13):4370-6.
[83] Nguyen S, Kuentz M, Vernant JP, Dhedin N, Bories D, Debre P, et al. Involvement of
mature donor T cells in the NK cell reconstitution after haploidentical hematopoietic
stem-cell transplantation. Leukemia 2008;22(2):344-52.
[84] Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, et al. Dif-
ferential cytokine and chemokine gene expression by human NK cells following activa-
tion with IL-18 or IL-15 in combination with IL-12: implications for the innate immune
response. J Immunol 1999;162(8):4511-20.
[85] Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, Waller EK, et al. NK cell education
after allogeneic transplantation: dissociation between recovery of cytokine-producing
and cytotoxic functions. Blood 2011;118(10):2784-92.
[86] Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, et al. CD-
56bright natural killer cells are present in human lymph nodes and are activated by T
cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood
2003;101(8):3052-7.
[87] Brahmi Z, Hommel-Berrey G, Smith F, Thomson B. NK cells recover early and medi-
ate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood
recipients. Hum Immunol 2001;62(8):782-90.
[88] Barker JN, Hough RE, van Burik JA, DeFor TE, MacMillan ML, O'Brien MR, et al. Serious
infections after unrelated donor transplantation in 136 children: impact of stem cell
source. Biol Blood Marrow Transplant 2005;11(5):362-70.
[89] Yu J, Venstrom JM, Liu XR, Pring J, Hasan RS, O'Reilly RJ, et al. Breaking tolerance to
self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit
effector function after T cell-depleted allogeneic hematopoietic cell transplantation.
Blood 2009;113(16):3875-84.
[90] Bjorklund AT, Schaffer M, Fauriat C, Ringden O, Remberger M, Hammarstedt C, et al.
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-
matched sibling stem cell transplantation. Blood 2010;115(13):2686-94.
[91] Wang H, Grzywacz B, Sukovich D, McCullar V, Cao Q, Lee AB, et al. The unexpected
effect of cyclosporin A on CD56+CD16− and CD56+CD16+ natural killer cell subpopu-
lations. Blood 2007;110(5):1530-9.
[92] Haas P, Loiseau P, Tamouza R, Cayuela JM, Moins-Teisserenc H, Busson M, et al. NK-
cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoi-
etic stem cell transplantation. Blood 2011;117(3):1021-9.
[93] Elliott JM, Wahle JA, Yokoyama WM. MHC class I-deficient natural killer cells acquire
a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp
Med 2010;207(10):2073-9.
[94] Joncker NT, Shifrin N, Delebecque F, Raulet DH. Mature natural killer cells reset
their responsiveness when exposed to an altered MHC environment. J Exp Med
2010;207(10):2065-72.
[95] Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, et al.
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in
patients with cancer. Blood 2005;105(8):3051-7.
[96] Shi J, Tricot G, Szmania S, Rosen N, Garg TK, Malaviarachchi PA, et al. Infusion of
haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for
relapsed myeloma in the setting of autologous stem cell transplantation. Br J Haematol
2008;143(5):641-53.

354